Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Sectors

Rigetti regulates $1.5bn reverse merger

The Bloomberg Beta-backed quantum chipmaker is joining forces with the publicly listed Supernova Partners Acquisition Company II.


Oct 7, 2021

Elemy elevates itself with $219m

SoftBank Vision Fund 2 led autistic childcare platform developer Elemy’s latest round, which valued it at $1.15bn.

Oct 7, 2021

Honor hones $370m series E

Prosus Ventures has returned to back an equity and debt round for the homecare management platform developer secured at a $1.25bn valuation.

Oct 7, 2021

Zum drives to $130m series D

The student transport service secured backing from SoftBank Vision Fund 2 and BMW i Ventures as it looks to fuel its expansion.

Oct 7, 2021

Lilac mines investors for $150m close

SK Materials, Presidio Ventures and BMW i Ventures were among the investors that helped the lithium mining process developer complete its series B round.

Oct 7, 2021

E-ctare harvests $120m capital commitment

The rural producer-focused digital credit provider is set to receive $120m from Conglomerado Alfa subsidiary Alfa Collab over three years.

Oct 7, 2021

Twin Health tracks $140m in series C

Helena backed Twin Health, the developer of a metabolic digital twin platform, in a round reportedly valuing it at $740m.

Oct 7, 2021

NeuroBlade processes $83m in series B funding

Intel, PSMC, UMC, Pegatron and Marubeni all chipped in for the artificial intelligence processor developer’s latest round, taking its total funding to over $110m.

Oct 7, 2021

The Mom Project attracts $80m

Citi and Silicon Valley Bank backed the recruitment platform for mothers in a series C round which brought the overall funding raised by the company to $116m.

Oct 7, 2021

Gap casts CB4 for acquisition

Tel Aviv University spinout CB4 has been bought by Gap after having raised at least $22m in equity financing.

Oct 7, 2021

GetSafe grows series B round to $93m

Swiss Re and CommerzVentures helped the digital insurer add $63m in series B funding which will be used to pursue its own insurance licence and boost European expansion.

Oct 7, 2021

Exscientia expands IPO to over $350m

The cancer drug developer has closed its initial public offering after underwriters exercised the greenshoe option.

Oct 7, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here